Cart is empty A team of researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has developed a point-of-care testing (POCT) system based on microfluidic CRISPR-Dx technology, significantly improving the sensitivity, speed, and multiplexing capability of pathogen detection.
Leave A Comment